Spyre Therapeutics, Inc. · NASDAQ:SYRE

Turtle Cameron sold 15,000 Spyre Therapeutics, Inc. shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 3, 2026

On Sep 1, 2026, Turtle Cameron (Director, Chief Executive Officer) sold 15,000 Spyre Therapeutics, Inc. shares at an average US$87.29 for US$1.31M under a trading plan, leaving 552,540 shares. Filed Sep 3, 2026 (Form 4).

Sold
15,000 shares
Price
US$87.29 average (US$86.36 to US$89.07)
Value
US$1.31M
Holding after
552,540 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockSale2,500US$86.36565,040Direct
Sep 1, 2026Common StockSale8,400US$87.15556,640Direct
Sep 1, 2026Common StockSale3,700US$88.06552,940Direct
Sep 1, 2026Common StockSale400US$89.07552,540Direct

Source

View original at SEC

Related